SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-048349
Filing Date
2020-10-28
Accepted
2020-10-28 16:16:21
Documents
3
Effectiveness Date
2020-10-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A abio-defa14a_20201028.htm DEFA14A 32266
2 GRAPHIC gbkkxnxt02ku000001.jpg GRAPHIC 82574
3 GRAPHIC gbkkxnxt02ku000002.jpg GRAPHIC 57597
  Complete submission text file 0001564590-20-048349.txt   226783
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-22873 | Film No.: 201268849
SIC: 2835 In Vitro & In Vivo Diagnostic Substances